AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques

Overview of attention for article published in Nature Medicine, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

twitter: 14 X users

facebook: 1 Facebook page

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 396,011 followers.

RT @NIH_ORIP: Researchers explore the efficacy of AZD5582 and SIV antibodies in HIV treatment, showcasing potential advancements in targeti…

Researchers explore the efficacy of AZD5582 and SIV antibodies in HIV treatment, showcasing potential advancements in targeting latent infections. @AnnChahroudi et al. @EmoryMedicine @EmoryPediatrics (ORIP support through P51OD011132, R01OD011095) https…

RT @NatureMedicine: Reactivation of latent SIV with an IAP antagonist, coupled with immunotherapeutic approaches, reduced replication-compe…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 11 additional X posts.